Potential Misdiagnosis of Factor V Leiden: A Comparison of Two Genotyping Techniques

Thromb Haemost 1997; 77(06): 1217
DOI: 10.1055/s-0038-1656141

Letters to the Editor

Schattauer GmbH Stuttgart

Authors

A M Cumming

The University Department of Haematology, Manchester Royal Infirmary, Manchester, U.K.
S Keeney

The University Department of Haematology, Manchester Royal Infirmary, Manchester, U.K.
A Salden

The University Department of Haematology, Manchester Royal Infirmary, Manchester, U.K.
D Shanks

The University Department of Haematology, Manchester Royal Infirmary, Manchester, U.K.
C R M Hay

The University Department of Haematology, Manchester Royal Infirmary, Manchester, U.K.

References
1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
2 Bertina RM, Koeleman PC, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van derVeldenP A, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
3 Koster T, Rosendaal FR, de RondeH, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
4 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
5 Liebman HA, Sutherland D, Bacon R, McGehee W. Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally available assay for activated protein C resistance. Br J Haematol 1996; 95: 550-553
6 Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503-2517